University of Oxford researchers, working in an unprecedented vaccine development effort to prevent COVID-19, have started screening healthy volunteers ahead of a vaccine trial. The NIHR Oxford Biomedical Research Centre (BRC) provided essential funding to get the trial up and running. The team will enrol healthy volunteers aged between 18 and 55, who, if they … Read more
Article addresses remote assessment of COVID-19 in primary care
An article by a leading Oxford researcher has outlined the guiding principles on how general practitioners should conduct remote consultations with patients who are suspected of having COVID-19. The article, published in the BMJ, is by Prof Trish Greenhalgh (pictured), the Oxford BRC Theme Lead for Partnerships for Health, Wealth and Innovation, and a Professor … Read more
Oxford researchers to play key role in fight-back against COVID-19
Researchers supported by the NIHR Oxford Biomedical Research Centre will play a crucial role in tackling the current COVID-19 pandemic, ranging from the development of a new vaccine to developing the most effective drug treatments for people who have contracted the virus. A team from the Oxford Vaccine Group and the University of Oxford’s Jenner … Read more
Oxford BRC statement on activities during the current COVID-19 situation
Many of the researchers we support are also clinicians, providing direct care to patients and the public, alongside their academic work. Given the scale of the national and global challenge of COVID-19 (coronavirus), BRC-funded clinical and research professionals who are working on topics other than COVID-19, or those with relevant skills, are being asked to … Read more
Researchers identify markers in joint fluid that could be key to cartilage repair
Oxford researchers have found that molecular changes in the joint fluid during knee distraction surgery reveal markers that may drive cartilage repair in osteoarthritis. It is generally accepted that cartilage is not able to heal or regenerate itself after injury or through wear and tear, leading to the development of osteoarthritis. But there is a … Read more
Athena SWAN “Europe’s most comprehensive gender equality scheme”
A study involving researchers from the NIHR Oxford Biomedical Research Centre (BRC) has found that institutions in the European Research Area could benefit from exploring Athena SWAN as the basis for their gender equality policies. The study found that Athena SWAN, with its contextually embedded systemic approach to dynamic action planning and inclusive focus on … Read more
New stroke research centre opens in Oxford
Research into strokes and vascular dementia took a major step forward on Thursday (5th March) with the official opening of the Wolfson Centre for the Prevention of Stroke and Dementia (CPSD) in Oxford, based at the new Wolfson Building at the John Radcliffe Hospital. The new centre is the only purpose-built clinical research centre looking … Read more
Top accolade for gestational diabetes app
A smartphone application for women with gestational diabetes, developed at Oxford University Hospitals (OUH) and the University of Oxford, has won a national award. GDm-Health won the MedTech, Device or Hardware Innovation Award at the HSJ Partnership Awards on Thursday (27th February). The app was developed initially as a ‘proof-of-concept’ collaboration between OUH’s Women’s Centre … Read more
Oxford BRC welcomes visitors to expand international links
The Oxford BRC has recently hosted leading healthcare groups from South Korea, Brazil and Turkey to expand its international links and identify opportunities for collaboration. During their visits, the foreign guests met the BRC management team, key researchers and industry partnership managers. They were given a tour of Old Road Campus, where a number of … Read more
Gene therapy shows promise in tackling common cause of childhood blindness
The results of a first-in-human clinical trial of gene therapy to treat a common cause of genetic blindness have shown partial reversal of sight loss in some patients. X-linked retinitis pigmentosa, caused by mutations in RPGR gene, is the most common cause of blindness in young people. The inherited mutations lead to degeneration of light … Read more
- 1
- 2
- 3
- …
- 48
- Next Page »